TransDigm (TDG) director gets 518 options at $1,291.97; 2035 exp
TransDigm Group (TDG) reported an insider equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TransDigm Group (TDG) reported an insider equity grant. Director W. Nicholas Howley received 518 stock options on 11/04/2025 at an exercise price of $1,291.97 per share. The options vest 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. Following the grant, 518 derivative securities were beneficially owned directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options are exercisable at 20% per year over five years beginning September 30, 2026 subject to the achievement of annual operating performance targets in each year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TransDigm (TDG) disclose in this Form 4?
What is the exercise price of the options granted to TDG's director?
How do the TDG options vest for W. Nicholas Howley?
When do the TransDigm options expire?
How many derivative securities were held after the reported TDG transaction?
What is the reporting person's relationship to TransDigm (TDG)?
AI-generated analysis. How Rhea-AI works. Not financial advice.